Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size.

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL ...

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

Women are missing out on crucial cardiac diagnoses due to outdated guidelines aimed at men, a study suggests. Research by the ...

Study warns of risks of intense training in young athletes: when does exercise benefit or harm children's hearts?

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...

HCM is a genetic condition where the muscular wall of the heart becomes thickened, making it harder for the heart to pump blood around the body.

An initiative to improve care and standardize identification, assessment, referrals, and treatment for patients with HCM has been launched by the AHA.